
Mold-Tek Packaging Reports Strong Start to FY27; Q1 Net Sales Hit 300 Crores as EBITDA Rises
Mold-Tek Packaging Limited has announced a robust beginning to Fiscal Year 2026-27, successfully navigating geopolitical uncertainties. The company reported strong growth across its business segments in the first quarter ended June 30, 2026, driven by operational excellence and enhanced capacity utilization.The company’s results demonstrate significant improvement compared to the previous year's corresponding period, with profitability metrics showing substantial increases.
Key Financial Highlights (Q1 FY27 vs Q1 FY26)
Mold-Tek achieved notable gains in key performance indicators during the quarter. The financial data highlights consistent growth across turnover and profitability:| Metric | Q1 FY27 Result | Growth Rate | Previous Period (Q1 FY26) |
|---|---|---|---|
| Net Sales | ¥300.45 crores | 24.90% | ¥240.56 crores |
| EBITDA | ¥56.43 crores | 19.10% | ¥47.38 crores |
| Net Profit (PAT) | 25.57 crores | 14.15% | ¥22.40 crores |
| Sales Volume | 12,089 MT | 6.25% | 11,378 MT |
Operational Consolidation and Efficiency Gains
The Chairman and Managing Director, Mr J Lakshmana Rao, attributed the strong all-round performance to unwavering focus on operational excellence and strategic consolidation initiatives within Hyderabad. The company has successfully consolidated five units into two major manufacturing units in Annaram and Sultanpur. This move streamlines operations, resulting in reduced overheads, inter-unit transfers, and product rejections.With capacity utilization reaching 75%, the company achieved a record EBITDA margin of Rs 46.68 per kg in Q1 FY27, marking an increase from Rs 41.64 per kg in Q1 FY26.
Segment Performance Analysis
The results showcased diversified segment strengths and strategic growth momentum:- Pharma Packaging: The new pharmaceutical vertical posted a strong sales volume growth of 38.75%. This success is expected to continue as the company plans future entry into Ophthalmic-Packs and diagnostics.
- Food & FMCG Packs: This segment registered a healthy 26.20% growth, supported by sustained market penetration. To meet rising demand in this area, the company commissioned eight additional injection moulding machines at its Sultanpur, Hyderabad facility. Furthermore, food and FMCG packs production at Panipat has been doubled.
- Paints Packs: The Paints segment showed a 10.82% growth, reflecting robust customer confidence and market anticipation for industry volume increases.
- Lube Packs: Demand in the Lubricant segment dipped during the quarter due to client supply issues related to inputs originating from the Iran war.
Financial Trajectory Overview (Q1 on Q4)
Beyond the year-on-year comparisons, management reviewed the results relative to the previous quarter, noting significant uplifts: Net Sales saw an increase of 26.32% compared to the previous quarter (Q4). Similarly, Net Profit (PAT) surged by 23.89%, and EBITDA grew by 17.31%, both indicating improved bottom-line performance driven by enhanced operational efficiency.Customer Acquisition and Future Vision
The company continues to expand its customer base in key industries. New clients secured during the quarter include Innovative Food, Alphonsa Cashew, Bakerville Specialities within the Food Industry, and Blackgoldust, Pharma Force Lab from the Pharma Industry.Looking ahead, Mold-Tek Packaging Limited is set to continue broadening its product range into high value segments. The company stated plans to explore entry into Electronics and Semi-conductor packaging in addition to nurturing its strong position in Pharma Packaging.
MOLDTKPAC Stock Price Movement
As of 2:25 PM, Mold-Tek Packaging Limited shares are slipping at ₹699.85, having shed 3.79% in live trading after a dip of ₹27.60. The equity saw heavy activity today, finishing significantly higher than its day low of ₹686.65 amidst a traded volume of 411,624 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.